The Government of Canada announces funding to support Dr. Wajd Alkabbani’s research to study access and outcomes of glucose monitoring devices
Continuous glucose monitoring (CGM) devices are small sensors that measure blood sugar throughout the day and night, giving people with diabetes timely information to help them manage their condition and avoid dangerous complications like very low blood sugar.
Dr. Wajd Alkabbani from Waterloo’s School of Pharmacy will assess how health policy, social factors and medical conditions affect who gets access to CGM in Canada and how well it works in preventing serious health problems.
“This project is about making sure that important diabetes technologies are reaching the people who need them most,” Alkabbani says.
CIHR is the Government of Canada’s health research investment agency that funds research across country to understand the complexities of health and support the development of policies and programs that improve the health of individuals and communities.